Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
WTKWY Stock Summary
Top 10 Correlated ETFs
WTKWY
In the News
Wolters Kluwer to announce further 1 billion euro share buyback, CFO says
Kevin Entricken, CFO of Wolters Kluwer, discusses the company's latest results and guidance for the year ahead.
What Makes Wolters Kluwer NV (WTKWY) a Good Fit for 'Trend Investing'
Wolters Kluwer NV (WTKWY) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Wolters Kluwer: Well-Managed, But Too Expensive For Me
Wolters Kluwer's primary listing is on Euronext Amsterdam, with a market cap of approximately 29B EUR. The company reported strong growth in the health and tax and accounting divisions, with a total revenue increase of 5% and organic growth rates of 6% and 8%, respectively. The company's free cash flow remains strong, but I consider the stock overvalued at 30 times earnings while the share buyback strategy is questionable.
Wolters Kluwer NV (WTKWY) Upgraded to Buy: Here's What You Should Know
Wolters Kluwer NV (WTKWY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Wolters Kluwer NV (WTKWY) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Wolters Kluwer NV (WTKWY) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
7 High-Risk, High-Reward Stocks That Could Pay Off Big-Time
If you are looking for some excitement in your portfolio, you might be tempted by high-risk, high-reward stocks. These are the stocks that can soar to the moon or crash to the ground, depending on how the market perceives their growth potential and profitability.
Best Momentum Stock to Buy for March 27th
WTKWY, KTB and CCU made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 27, 2023.
All You Need to Know About Wolters Kluwer NV (WTKWY) Rating Upgrade to Strong Buy
Wolters Kluwer NV (WTKWY) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Wolters Kluwer N.V. (WOLTF) Q4 2022 Earnings Call Transcript
Wolters Kluwer N.V. (OTCPK:WOLTF) Q4 2022 Earnings Conference Call February 22, 2023 4:00 AM ET Company Participants Margaret Geldens - VP, IR Nancy McKinstry - CEO Kevin Entricken - CFO Conference Call Participants Adam Berlin - UBS Nick Dempsey - Barclays Omar Sheikh - Morgan Stanley Silvia Cunio - Deutsche Bank Tom Singlehurst - Citi Sami Kassab - BNP Paribas Lisa Yang - Goldman Sachs Matthew Walker - Credit Suisse Henk Slotboom - The Idea Konrad Zomer - ABN AMRO Operator Hello everyone, and welcome to the Wolters Kluwer Full Year 2022 Results Webcast and Conference Call.
Best Growth Stocks to Buy for January 26th
A, WTKWY and KNBE made it to the Zacks Rank #1 (Strong Buy) growth stocks list on January 26, 2023.
WTKWY Financial details
WTKWY Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 16.94 | 17.27 | 18.22 | 21.32 | 22.7 | |
Net income per share | 2.46 | 2.7 | 2.78 | 4.01 | 4.09 | |
Operating cash flow per share | 4.05 | 4.49 | 4.94 | 6.18 | 6.28 | |
Free cash flow per share | 3.22 | 3.6 | 4.02 | 5.03 | 4.97 | |
Cash per share | 3.09 | 2.63 | 3.75 | 5.13 | 4.54 | |
Book value per share | 8.74 | 7.83 | 9.23 | 9.03 | 7.11 | |
Tangible book value per share | -12.17 | -13.32 | -12.92 | -14.59 | -16.96 | |
Share holders equity per share | 8.74 | 7.83 | 9.23 | 9.03 | 7.11 | |
Interest debt per share | 11.66 | 11.9 | 12.2 | 14.35 | 15.31 | |
Market cap | 17.61B | 18.47B | 27.31B | 25.12B | 31.18B | |
Enterprise value | 19.82B | 20.85B | 29.44B | 27.38B | 33.78B | |
P/E ratio | 26.32 | 25.62 | 37.51 | 24.45 | 30.96 | |
Price to sales ratio | 3.82 | 4.01 | 5.72 | 4.61 | 5.58 | |
POCF ratio | 15.98 | 15.43 | 21.14 | 15.88 | 20.18 | |
PFCF ratio | 20.1 | 19.26 | 25.96 | 19.51 | 25.52 | |
P/B Ratio | 7.4 | 8.85 | 11.3 | 10.87 | 17.83 | |
PTB ratio | 7.4 | 8.85 | 11.3 | 10.87 | 17.83 | |
EV to sales | 4.3 | 4.53 | 6.17 | 5.02 | 6.05 | |
Enterprise value over EBITDA | 14.72 | 14.46 | 20.3 | 16.12 | 18.96 | |
EV to operating cash flow | 17.98 | 17.42 | 22.79 | 17.31 | 21.87 | |
EV to free cash flow | 22.62 | 21.74 | 27.98 | 21.28 | 27.65 | |
Earnings yield | 0.04 | 0.04 | 0.03 | 0.04 | 0.03 | |
Free cash flow yield | 0.05 | 0.05 | 0.04 | 0.05 | 0.04 | |
Debt to equity | 1.31 | 1.48 | 1.29 | 1.56 | 2.14 | |
Debt to assets | 0.35 | 0.37 | 0.35 | 0.38 | 0.41 | |
Net debt to EBITDA | 1.64 | 1.65 | 1.47 | 1.34 | 1.46 | |
Current ratio | 0.65 | 0.69 | 0.9 | 0.77 | 0.73 | |
Interest coverage | 13.55 | 13.14 | 15.81 | 23.39 | 49 | |
Income quality | 1.65 | 1.66 | 1.77 | 1.54 | 1.53 | |
Dividend Yield | 0.02 | 0.02 | 0.01 | 0.02 | 0.01 | |
Payout ratio | 0.42 | 0.46 | 0.51 | 0.41 | 0.46 | |
Sales general and administrative to revenue | 0.19 | 0.2 | 0.19 | 0.18 | 0.31 | |
Research and developement to revenue | 0.1 | 0.09 | 0.1 | 0.1 | 0.11 | |
Intangibles to total assets | 0.65 | 0.67 | 0.64 | 0.64 | 0.65 | |
Capex to operating cash flow | -0.21 | -0.2 | -0.19 | -0.19 | -0.21 | |
Capex to revenue | -0.05 | -0.05 | -0.05 | -0.05 | -0.06 | |
Capex to depreciation | -0.54 | -0.56 | -0.57 | -0.68 | -0.73 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Graham number | 21.99 | 21.83 | 24.03 | 28.56 | 25.59 | |
ROIC | 0.12 | 0.14 | 0.13 | 0.17 | 0.18 | |
Return on tangible assets | 0.22 | 0.26 | 0.23 | 0.3 | 0.32 | |
Graham Net | -16.72 | -17.6 | -17.83 | -18.94 | -20.47 | |
Working capital | -1.33B | -968M | -318M | -892M | -1.04B | |
Tangible asset value | -3.31B | -3.55B | -3.38B | -3.73B | -4.17B | |
Net current asset value | -3.92B | -4.11B | -3.87B | -4.22B | -4.59B | |
Invested capital | 1.31 | 1.48 | 1.29 | 1.56 | 2.14 | |
Average receivables | 1.25B | 1.22B | 1.2B | 1.29B | 1.44B | |
Average payables | 283M | 151M | 128M | 135M | 572M | |
Average inventory | 74M | 70.5M | 66.5M | 72M | 81.5M | |
Days sales outstanding | 101.93 | 91.82 | 94.79 | 89.69 | 100.34 | |
Days payables outstanding | 44.54 | 35.72 | 32.67 | 34 | 230.9 | |
Days of inventory on hand | 19.24 | 18.26 | 17.27 | 18.27 | 19.45 | |
Receivables turnover | 3.58 | 3.97 | 3.85 | 4.07 | 3.64 | |
Payables turnover | 8.2 | 10.22 | 11.17 | 10.73 | 1.58 | |
Inventory turnover | 18.97 | 19.99 | 21.14 | 19.97 | 18.76 | |
ROE | 0.28 | 0.35 | 0.3 | 0.44 | 0.58 | |
Capex per share | -0.83 | -0.89 | -0.92 | -1.15 | -1.31 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 9.55 | 10.07 | 11.24 | 10.99 | 11.7 | |
Net income per share | 1.41 | 1.76 | 2.25 | 1.93 | 2.16 | |
Operating cash flow per share | 0 | 0 | 3.61 | 2.75 | 3.53 | |
Free cash flow per share | 0 | 0 | 2.99 | 2.11 | 2.85 | |
Cash per share | 3.76 | 4.18 | 5.16 | 4.43 | 4.57 | |
Book value per share | 9.26 | 10.19 | 9.1 | 8.08 | 7.16 | |
Tangible book value per share | -12.97 | -13.49 | -14.7 | -16.05 | -17.06 | |
Share holders equity per share | 9.26 | 10.19 | 9.1 | 8.08 | 7.16 | |
Interest debt per share | 12.15 | 12.92 | 14.29 | 14.5 | 15.35 | |
Market cap | 27.22B | 24.04B | 24.93B | 29.01B | 30.98B | |
Enterprise value | 29.35B | 26.24B | 27.2B | 31.48B | 33.59B | |
P/E ratio | 18.49 | 13.21 | 10.9 | 15.14 | 14.67 | |
Price to sales ratio | 10.93 | 9.25 | 8.74 | 10.65 | 10.84 | |
POCF ratio | 0 | 0 | 27.22 | 42.6 | 35.86 | |
PFCF ratio | 0 | 0 | 32.8 | 55.36 | 44.45 | |
P/B Ratio | 11.26 | 9.14 | 10.79 | 14.48 | 17.71 | |
PTB ratio | 11.26 | 9.14 | 10.79 | 14.48 | 17.71 | |
EV to sales | 11.78 | 10.09 | 9.53 | 11.55 | 11.75 | |
Enterprise value over EBITDA | 38.41 | 29.92 | 31.89 | 36.73 | 36.59 | |
EV to operating cash flow | 0 | 0 | 29.69 | 46.22 | 38.87 | |
EV to free cash flow | 0 | 0 | 35.79 | 60.07 | 48.19 | |
Earnings yield | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | |
Free cash flow yield | 0 | 0 | 0.03 | 0.02 | 0.02 | |
Debt to equity | 1.29 | 1.25 | 1.56 | 1.79 | 2.14 | |
Debt to assets | 0.35 | 0.35 | 0.38 | 0.39 | 0.41 | |
Net debt to EBITDA | 2.79 | 2.5 | 2.66 | 2.88 | 2.84 | |
Current ratio | 0.9 | 0.71 | 0.77 | 0.75 | 0.73 | |
Interest coverage | 11.9 | 15.38 | 44.14 | 63.6 | 49.57 | |
Income quality | 0 | 0 | 1.6 | 1.42 | 1.64 | |
Dividend Yield | 0 | 0 | 0.01 | 0.01 | 0.01 | |
Payout ratio | 0 | 0 | 0.28 | 0.52 | 0.42 | |
Sales general and administrative to revenue | 0.32 | 0.31 | 0.31 | 0.32 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.64 | 0.65 | 0.64 | 0.66 | 0.65 | |
Capex to operating cash flow | 0 | 0 | -0.17 | -0.23 | -0.19 | |
Capex to revenue | 0 | 0 | -0.05 | -0.06 | -0.06 | |
Capex to depreciation | 0 | 0 | -0.66 | -0.71 | -0.75 | |
Stock based compensation to revenue | 0 | 0 | 0.01 | 0.01 | -0.16 | |
Graham number | 17.14 | 20.1 | 21.47 | 18.73 | 18.65 | |
ROIC | 0.07 | 0.08 | 0.08 | 0.08 | 0.09 | |
Return on tangible assets | 0.11 | 0.14 | 0.16 | 0.15 | 0.17 | |
Graham Net | -17.89 | -17.58 | -19.08 | -19.55 | -20.6 | |
Working capital | -318M | -1.14B | -892M | -865M | -1.04B | |
Tangible asset value | -3.38B | -3.48B | -3.73B | -3.98B | -4.17B | |
Net current asset value | -3.87B | -4B | -4.22B | -4.43B | -4.59B | |
Invested capital | 1.29 | 1.25 | 1.56 | 1.79 | 2.14 | |
Average receivables | 1.28B | 1.38B | 1.43B | 1.4B | 1.5B | |
Average payables | 428M | 468M | 480M | 525M | 950M | |
Average inventory | 68M | 69M | 76M | 79M | 81.5M | |
Days sales outstanding | 44.77 | 52.72 | 42.27 | 48.29 | 48.32 | |
Days payables outstanding | 13.31 | 88.58 | 14.51 | 104.59 | 87.71 | |
Days of inventory on hand | 7.03 | 7.95 | 7.8 | 9.15 | 7.39 | |
Receivables turnover | 2.01 | 1.71 | 2.13 | 1.86 | 1.86 | |
Payables turnover | 6.76 | 1.02 | 6.2 | 0.86 | 1.03 | |
Inventory turnover | 12.8 | 11.32 | 11.54 | 9.84 | 12.18 | |
ROE | 0.15 | 0.17 | 0.25 | 0.24 | 0.3 | |
Capex per share | 0 | 0 | -0.61 | -0.63 | -0.68 |
WTKWY Frequently Asked Questions
What is Wolters Kluwer N.V. stock symbol ?
Wolters Kluwer N.V. is a NL stock and trading under the symbol WTKWY
What is Wolters Kluwer N.V. stock quote today ?
Wolters Kluwer N.V. stock price is $157.07 today.
Is Wolters Kluwer N.V. stock public?
Yes, Wolters Kluwer N.V. is a publicly traded company.